Allergy & Immunology  
The MD Magazine Allergy & Immunology condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Amgen Takes Aim at Sanofi and Regeneron Blockbuster Dupilumab
Already at war over PCSK9, drug giants go to court over another breakthrough drug.
The FDA contraindicated using LABA as monotherapy in adults with asthma.
Newfound association a step towards creating cytokine profiles for asthma phenotypes.
Reslizumab can improve lung functions in certain asthmatic patients.
Meredith McCormack, MD, MHS, talked about managing asthma and COPD in the primary care setting and when it’s time to refer a patient to a specialist at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California.
Asthma responds differently to specific treatment regimens based on subtypes.
Omalizumab therapy reduces exacerbations in severe allergic asthma patients.
Accorda vows to appeal court's patent invalidations.
Highly anticipated potential first-line treatment now a go in the United States.

Most Popular


$vacMongoViewPlus$ $vAR$